Viraraghavan V Ramaswamy

Neonatologist

[Dr. S. Jaishankar @DrSJaishankar]

Good to meet Deputy PM @AngelaRayner today in Manchester.

Her encouragement has been a contribution to setting up of our Consulate.

Also discussed 🇮🇳 🇬🇧 bilateral ties and our efforts on increasing trade and people to people exchanges.

[Viraraghavan V Ramaswamy @viraraghavan7]

NNF, India CPG on interventions to mitigate pain in neonates : SR/NMA which paved the way for the recommendations. Great initiative from an LMIC. Freely available as open access and CPG in magic app website. @SumanRaoPN @ProfSomashekhar @Atul_Monash @amitguptabliss

[Viraraghavan V Ramaswamy @viraraghavan7]

Vitamin D supplementation in infancy, become a universal practice. Since long, researchers attributed almost every other disease to Vitamin D def! We evaluated the different regimens in this NMA. https://t.co/Pc3aXmsRHb
@ccroehr @drbretty @amitguptabliss @ProfSomashekhar

[Viraraghavan V Ramaswamy @viraraghavan7]

@souvik_neo @ccroehr @drbretty @jennifer3050 @ProfSomashekhar @DrAbdulRazak_MD @neosatyan Thanks Souvik. Thoughts are partially in what this ‘study adds’? A very important question I accept.👍

[Viraraghavan V Ramaswamy @viraraghavan7]

Sharing the NNF, India Systematic review based on which CPG was formulated. Tough PICO. Please do read and provide your valuable inputs. https://t.co/kVrbeC33PQ @ccroehr @drbretty @jennifer3050 @ProfSomashekhar @DrAbdulRazak_MD @souvik_neo @neosatyan

[Viraraghavan V Ramaswamy @viraraghavan7]

@DrAbdulRazak_MD @ccroehr @drbretty @jennifer3050 @ProfSomashekhar @souvik_neo @neosatyan Thank you Razak. Completely agree with your comments. May be a viewpoint could be written on this? But now you have become a real researcher!😊

[Viraraghavan V Ramaswamy @viraraghavan7]

@drbretty @ccroehr @jennifer3050 @ProfSomashekhar @DrAbdulRazak_MD @souvik_neo @neosatyan @HebertAudrey3 Thank you. Most still use dopamine as first line in all types of shock and that too at very high doses until adding a second inotrope/ vasopressor. HC is considered at a very late stage. That is the usual norm here and UK as I have observed and heard in discussions.

[Viraraghavan V Ramaswamy @viraraghavan7]

@DrAbdulRazak_MD @CochraneNeonate @PASMeeting @mukerji_amit @cochranemthds @cochranecollab @SCSMonash @MonashUni @McMasterU @EBNEO @nicupodcast @UofT Congratulations. Was the first two NMAs I did. A topic close to my heart 😊 Will go through and get back. Wishes again Abdul

[Prof.Dr. Somashekhar Nimbalkar,MD,PGDPH,FNNF,FIAP @ProfSomashekhar]

Due to personal reasons had dropped out of going to Canada for the same meeting. Think I saved myself a lot of time & stress. @DrSJaishankar @PMOIndia we need to raise this with @HCCanIN officially.

[Viraraghavan V Ramaswamy @viraraghavan7]

@DrAbdulRazak_MD @ProfSomashekhar @CanadainIndia Not a personal issue. I represent India in the meet @HCCanIN I do not want to go to a country that does not respect mine @DrSJaishankar But I cannot bring my personal bias into health policy MEA did what they could @HCCanIN was ambiguous in their response @PMOIndia @narendramodi

[Viraraghavan V Ramaswamy @viraraghavan7]

@CanadainIndia V402300918 Despite multiple requests to process application to attend ILCORmeet Toronto as TaskForce Member faculty from DevelopingNation for the betterment of newbornhealth got no response. Submitted application March8 Biometrics March28.Have to fly April30

[Viraraghavan V Ramaswamy @viraraghavan7]

@HCCanInd Invited to Toronto for @Ilcor_org meet to rep Newborn Indian RCF, rebuked @ Consulate canada. Mixed newborn health and politics @HCCanIN Will raise in next meet @ Taipei. @DrSJaishankar request MEA to b helpful. No response at MEA today . Still waiting till tomorrow.

[Evidence-Based Neo @EBNEO]

Severity of BPD (depending on the classification system) and respiratory and neurodevelopmental outcomes at 7-8 years in a 2005-born Australian cohort from @ProfLexDoyle et al. in @JPediatr https://t.co/S0JIbWMcWp #EBNEOalerts #neoEBM #FOAMneo #neotwitter

[Viraraghavan V Ramaswamy @viraraghavan7]

Sharing a review article of ours. New things to learn, please do read.

https://t.co/9EbeEiutQ3

@ProfSomashekhar @DrAbdulRazak_MD @ccroehr @neosatyan @souvik_neo

[Viraraghavan V Ramaswamy @viraraghavan7]

The following ILCOR draft CoSTR statements have been posted at https://t.co/7DK1KXII9D for public comment.
 Cord Management at Birth for Preterm Infants: NLS 5051 Task Force Systematic Review (Link https://t.co/XeSAlm0Mvo)
Kindly provide your comments and share with others.

[Satyan @neosatyan]

An illustrated review of Pulmonary Hypertension in Developmental Lung Diseases - Clinics in Perinatology https://t.co/N0XVA6b9sx @TBX4_Life @AAPneonatal @atscommunity @NeoHemodynamics

[Viraraghavan V Ramaswamy @viraraghavan7]

An update on non- invasive respiratory support, invited review. Unexplored areas, budding neonatal researchers may work on these aspects@

[Viraraghavan V Ramaswamy @viraraghavan7]

Sharing our recent Cochrane review on anti-seizure medications in neonates. Kudos to the first author Abiramalatha for coordinating the work efficiently. @ccroehr @neosatyan @souvik_neo @DrAbdulRazak_MD @EBNEO @Abiramalatha_Dr @ProfSomashekhar @amitguptabliss

[Viraraghavan V Ramaswamy @viraraghavan7]

@DrAbdulRazak_MD @jennifer3050 @ProfSomashekhar @Ilcor_org @souvik_neo @ccroehr @neosatyan I got your point now. It’s not reflected in the abstract (word limit constraints) for such an exhaustive review. But please go through the reporting in the results section. It’s almost in sync with what you had indicated.

[Viraraghavan V Ramaswamy @viraraghavan7]

ILCOR’s Systematic review and meta-analysis on hypothermia prevention in preterm neonates less than 34 weeks. Thank you all the co-authors and ILCOR team @jennifer3050

https://t.co/z79kmjXGNy
@ProfSomashekhar @Ilcor_org @DrAbdulRazak_MD @souvik_neo @ccroehr @neosatyan

[Viraraghavan V Ramaswamy @viraraghavan7]

@DrAbdulRazak_MD @jennifer3050 @ProfSomashekhar @Ilcor_org @souvik_neo @ccroehr @neosatyan Hi Abdul. The ILCOR has adapted the GRADE guidelines for reporting of findings of SRs which you find in the supplement. If you remember we used the same approach for the RAM cannula review.